Literature DB >> 31573822

Role of Patient Maximizing-Minimizing Preferences in Thyroid Cancer Surveillance.

Joshua M Evron1, David Reyes-Gastelum2, Mousumi Banerjee2, Laura D Scherer3, Lauren P Wallner2, Ann S Hamilton4, Kevin C Ward5, Sarah T Hawley2, Brian J Zikmund-Fisher2, Megan R Haymart2.   

Abstract

PURPOSE: To understand the effect of patient preferences on thyroid cancer surveillance intensity. PATIENTS AND METHODS: Eligible patients diagnosed with thyroid cancer between January 1, 2014, and December 31, 2015, from the Georgia and Los Angeles County SEER registries were surveyed between February 2017 and October 2018 (N = 2,632; response rate, 63%). Patient reports on health care utilization in the past year and responses to the validated Medical Maximizer-Minimizer Scale were linked to SEER data in the 2,183 disease-free patients. Ordered logistic regression was performed using a cumulative logit with nonproportional odds.
RESULTS: Of disease-free patients, 31.6% were classified as minimizers, 42.5% as moderate maximizers, and 25.9% as strong maximizers. In the past year, 25.2%, 27.3%, and 38.5% of minimizers, moderate maximizers, and strong maximizers, respectively, had ≥ 4 doctor visits, and 18.3%, 24.9%, and 29.5%, respectively, had ≥ 2 neck ultrasounds. When controlling for age, sex, race and ethnicity, comorbidity, stage, and SEER site, strong maximizers (compared with minimizers) were significantly more likely to report ≥ 4 doctor visits (odds ratio [OR], 1.45; 95% CI, 1.10-1.92), ≥ 2 neck ultrasounds (OR, 1.58; 95% CI, 1.17-2.14), ≥ 1 radioactive iodine scan (OR, 1.73; 95% CI, 1.19-2.50), and ≥ 1 additional imaging study (OR, 2.06; 95% CI, 1.56-2.72).
CONCLUSION: Among patients with thyroid cancer who have been declared disease free, preference for a more maximal versus minimal approach to medical care is associated with increased number of physician visits and imaging tests. Because increased surveillance does not clearly correlate with improved outcomes, poses potential risks to patients, and contributes to increased healthcare costs, stronger consideration of the role of patient preferences is necessary when framing discussions on surveillance.

Entities:  

Mesh:

Year:  2019        PMID: 31573822      PMCID: PMC6839910          DOI: 10.1200/JCO.19.01411

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN: 0732-183X            Impact factor:   50.717


  24 in total

1.  Self-report by elderly breast cancer patients was an acceptable alternative to surveillance, epidemiology, and end results (SEER) abstract data.

Authors:  Mario Schootman; Donna B Jeffe; Michele M West; Rebecca Aft
Journal:  J Clin Epidemiol       Date:  2005-08-25       Impact factor: 6.437

2.  Curbing Unnecessary and Wasted Diagnostic Imaging.

Authors:  Ohad Oren; Electron Kebebew; John P A Ioannidis
Journal:  JAMA       Date:  2019-01-22       Impact factor: 56.272

3.  Trends in imaging after diagnosis of thyroid cancer.

Authors:  Jaime L Wiebel; Mousumi Banerjee; Daniel G Muenz; Francis P Worden; Megan R Haymart
Journal:  Cancer       Date:  2015-01-06       Impact factor: 6.860

4.  Increasing incidence of thyroid cancer in the United States, 1973-2002.

Authors:  Louise Davies; H Gilbert Welch
Journal:  JAMA       Date:  2006-05-10       Impact factor: 56.272

5.  Projections of the cost of cancer care in the United States: 2010-2020.

Authors:  Angela B Mariotto; K Robin Yabroff; Yongwu Shao; Eric J Feuer; Martin L Brown
Journal:  J Natl Cancer Inst       Date:  2011-01-12       Impact factor: 13.506

6.  Use of radioactive iodine for thyroid cancer.

Authors:  Megan R Haymart; Mousumi Banerjee; Andrew K Stewart; Ronald J Koenig; John D Birkmeyer; Jennifer J Griggs
Journal:  JAMA       Date:  2011-08-17       Impact factor: 56.272

7.  Increasing incidence of differentiated thyroid cancer in the United States, 1988-2005.

Authors:  Amy Y Chen; Ahmedin Jemal; Elizabeth M Ward
Journal:  Cancer       Date:  2009-08-15       Impact factor: 6.860

8.  Effectiveness of routine ultrasonographic surveillance of patients with low-risk papillary carcinoma of the thyroid.

Authors:  Laura Y Wang; Benjamin R Roman; Frank L Palmer; R Michael Tuttle; Ashok R Shaha; Jatin P Shah; Snehal G Patel; Ian Ganly
Journal:  Surgery       Date:  2015-12-31       Impact factor: 3.982

9.  Development of the Medical Maximizer-Minimizer Scale.

Authors:  Laura D Scherer; Tanner J Caverly; James Burke; Brian J Zikmund-Fisher; Jeffrey T Kullgren; Douglas Steinley; Denis M McCarthy; Meghan Roney; Angela Fagerlin
Journal:  Health Psychol       Date:  2016-09-12       Impact factor: 4.267

10.  Basis for physician recommendations for adjuvant radioiodine therapy in early-stage thyroid carcinoma: principal findings of the Canadian-American thyroid cancer survey.

Authors:  Anna M Sawka; David P Goldstein; Lehana Thabane; James D Brierley; Richard W Tsang; Lorne Rotstein; Shamila Kamalanathan; Boyu Zhao; Amiram Gafni; Sharon Straus; Shereen Ezzat
Journal:  Endocr Pract       Date:  2008-03       Impact factor: 3.443

View more
  12 in total

1.  Using Tailored Messages to Target Overuse of Low-Value Breast Cancer Care in Older Women.

Authors:  Lesly A Dossett; Nicole M Mott; Brooke C Bredbeck; Ton Wang; Chad Tc Jobin; Tasha M Hughes; Sarah T Hawley; Brian J Zikmund-Fisher
Journal:  J Surg Res       Date:  2021-11-19       Impact factor: 2.192

Review 2.  Disparities in Thyroid Care.

Authors:  Debbie W Chen; Michael W Yeh
Journal:  Endocrinol Metab Clin North Am       Date:  2022-05-04       Impact factor: 4.748

3.  Change in worry over time among Hispanic women with thyroid cancer.

Authors:  Nina Jackson Levin; Anao Zhang; David Reyes-Gastelum; Debbie W Chen; Ann S Hamilton; Bradley Zebrack; Megan R Haymart
Journal:  J Cancer Surviv       Date:  2021-10-11       Impact factor: 4.062

4.  Physician Confidence in Neck Ultrasonography for Surveillance of Differentiated Thyroid Cancer Recurrence.

Authors:  Kevin J Kovatch; David Reyes-Gastelum; Jennifer A Sipos; Elaine M Caoili; Ann S Hamilton; Kevin C Ward; Megan R Haymart
Journal:  JAMA Otolaryngol Head Neck Surg       Date:  2020-12-23       Impact factor: 6.223

5.  Medical Maximizing-Minimizing Preferences in Relation to Low-Value Services for Older Women with Hormone Receptor-Positive Breast Cancer: A Qualitative Study.

Authors:  Nicole Mott; Ton Wang; Jacquelyn Miller; Nicholas L Berlin; Sarah Hawley; Reshma Jagsi; Brian J Zikmund-Fisher; Lesly A Dossett
Journal:  Ann Surg Oncol       Date:  2020-07-27       Impact factor: 5.344

6.  Thyrotropin Suppression for Papillary Thyroid Cancer: A Physician Survey Study.

Authors:  Maria Papaleontiou; Debbie W Chen; Mousumi Banerjee; David Reyes-Gastelum; Ann S Hamilton; Kevin C Ward; Megan R Haymart
Journal:  Thyroid       Date:  2021-04-23       Impact factor: 6.506

7.  Promoting Reflection on Medical Maximizing-Minimizing Preferences May Create Undesired Effects on Decisions About Low-Benefit and High-Benefit Care.

Authors:  Brian J Zikmund-Fisher; Victoria A Shaffer; Laura D Scherer
Journal:  MDM Policy Pract       Date:  2021-01-29

8.  Translation and validation of the Chinese version of medical maximizer-minimizer scale: a cross-sectional study.

Authors:  Fenghua Lai; Ling Pei; Shufan Yue; Xiaopei Cao; Haipeng Xiao; Yanbing Li; Jin Li
Journal:  BMJ Open       Date:  2021-01-06       Impact factor: 2.692

9.  Physician management of thyroid cancer patients' worry.

Authors:  Maria Papaleontiou; Bradley Zebrack; David Reyes-Gastelum; Andrew J Rosko; Sarah T Hawley; Ann S Hamilton; Kevin C Ward; Megan R Haymart
Journal:  J Cancer Surviv       Date:  2020-09-16       Impact factor: 4.062

Review 10.  Thyroid Lobectomy for Low to Intermediate Risk Differentiated Thyroid Cancer.

Authors:  Dana M Hartl; Joanne Guerlain; Ingrid Breuskin; Julien Hadoux; Eric Baudin; Abir Al Ghuzlan; Marie Terroir-Cassou-Mounat; Livia Lamartina; Sophie Leboulleux
Journal:  Cancers (Basel)       Date:  2020-11-06       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.